Condition
ACL Tears
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Enrolling By Invitation1
Withdrawn1
Completed1
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07046000Not Yet RecruitingPrimary
MRI Evaluation of Graft Maturation Following ACL Reconstruction
NCT06948591RecruitingPrimary
BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures
NCT07115056Phase 4Withdrawn
Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction
NCT06781021Not ApplicableEnrolling By InvitationPrimary
The Effect of Tranexamic Acid Vs Torniquet on Visual Clarity in Knee Arthroscopic ACL Reconstruction
NCT03132987Not ApplicableCompletedPrimary
Characterizing Clinical and Biomechanical Contributions to Function Following ACL Reconstruction
Showing all 5 trials